Portfolio company
PainReform
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mimetic Medicines
This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.
Allay Therapeutics
The company develops long-acting localized pain management technology for patients recovering from surgery.
Latigo
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.
AmacaThera
The company develops injectable hydrogel drug delivery platforms for pharmaceutical partners to provide sustained post-surgical pain management and localised therapeutic release.
Latigo Biotherapeutics
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.
Vapogenix
Vapogenix develops topical non-opioid analgesics to treat localised pain from wounds and inflammatory conditions for patients requiring non-narcotic relief.
Brixton Biosciences
This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.
Egalet
This pharmaceutical company develops and commercialises abuse-deterrent oral medicines to treat acute and chronic pain for patients and healthcare providers.
